A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia
Clinical trial NCT01263704 · COMPLETED
Trial details
- NCT number
- NCT01263704
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-17
- Primary completion
- 2017-04-03
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.